Publications by authors named "A Lacroux"
Resume screening assisted by decision support systems that incorporate artificial intelligence is currently undergoing a strong development in many organizations, raising technical, managerial, legal, and ethical issues. The purpose of the present paper is to better understand the reactions of recruiters when they are offered algorithm-based recommendations during resume screening. Two polarized attitudes have been identified in the literature on users' reactions to algorithm-based recommendations: algorithm aversion, which reflects a general distrust and preference for human recommendations; and automation bias, which corresponds to an overconfidence in the decisions or recommendations made by algorithmic decision support systems (ADSS).
View Article and Find Full Text PDFArticle Synopsis
- EMAP (Extensive Macular Atrophy with Pseudodrusen) is a newly identified form of maculopathy that shares features with Age-related Macular Disease (AMD) but has an earlier onset and a distinct progression, starting with night blindness and leading to severe vision loss.
- EMAP incidence varies regionally, being lower in areas with a Mediterranean diet, while higher rates are found in locations with intense farming or industrial activities; toxic exposure during work is also noted as a significant risk factor.
- The study suggests that EMAP may result from lifelong toxic exposure leading to chronic inflammation and irregularities in complement pathways, causing severe retinal damage around the age of 50.
To revisit the autosomal dominant Sorsby fundus dystrophy (SFD) as a syndromic condition including late-onset pulmonary disease. We report clinical and imaging data of ten affected individuals from 2 unrelated families with SFD and carrying heterozygous TIMP3 mutations (c.572A > G, p.
View Article and Find Full Text PDFPurpose: To assess the association of clinical and biological factors with extensive macular atrophy with pseudodrusen (EMAP) characterized by bilateral macular atrophy occurring in patients aged 50 to 60 years and a rapid progression to legal blindness within 5 to 10 years.
Design: A national matched case-control study.
Participants: Participants were recruited in 10 French Departments of Ophthalmology and their associated clinical investigation centers.